Bone Marrow Transplantation - Table of Contents alert Volume 48 Issue 6

TABLE OF CONTENTS Volume 48, Issue 6 (June 2013) In this issue Reviews Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Take part in our reader survey for a chance to win a MacBook Air   As a reader of NPG's clinical and society-owned journals, we invite you to take part in a survey on your use of our journals and their associated websites. Take the survey and be entered into a prize draw for a MacBook Air* *Terms & conditions apply    Reviews Top Live (vaccines) from New York C J Forlenza and T N Small Bone Marrow Transplant 2013 48: 749-754; advance online publication, August 13, 2012; 10.1038/bmt.2012.141 Abstract | Full Text Biomarkers for acute GVHD: can we predict the unpredictable? Y-B Chen and C S Cutler Bone Marrow Transplant 2013 48: 755-760; advance online publication, August 6, 2012; 10.1038/bmt.2012.143 Abstract | Full Text Original Articles Top CONDITIONING REGIMENS Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT R Martino, L de Wreede, M Fiocco, A van Biezen, P A von dem Borne, R-M Hamladji, L Volin, M Bornhäuser, M Robin, V Rocha, T de Witte, N Kröger, M Mohty and for the Acute Leukemia Working Party the subcommittee for Myelodysplastic Syndromes of the Chronic Malignancies Working Party of the European group for Blood Marrow Transplantation Group (EBMT) Bone Marrow Transplant 2013 48: 761-770; advance online publication, December 3, 2012; 10.1038/bmt.2012.236 Abstract | Full Text STEM CELL PROCUREMENT Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT W A Wood, J Whitley, R Goyal, P M Brown, A Sharf, R Irons, K V Rao, A Essenmacher, J S Serody, J M Coghill, P M Armistead, S Sarantopoulos, D A Gabriel and T C Shea Bone Marrow Transplant 2013 48: 771-776; advance online publication, November 19, 2012; 10.1038/bmt.2012.216 Abstract | Full Text Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program P Shaughnessy, J Uberti, S Devine, R T Maziarz, J Vose, I Micallef, E Jacobsen, J McCarty, P Stiff, A Artz, E D Ball, R Berryman, M Dugan, R Joyce, F J Hsu, D Johns and P McSweeney Bone Marrow Transplant 2013 48: 777-781; advance online publication, November 26, 2012; 10.1038/bmt.2012.219 Abstract | Full Text CORD BLOOD STEM CELLS Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin F Ostronoff, F Milano, T Gooley, J A Gutman, P McSweeney, F B Petersen, B M Sandmaier, R Storb and C Delaney Bone Marrow Transplant 2013 48: 782-786; advance online publication, December 17, 2012; 10.1038/bmt.2012.243 Abstract | Full Text PEDIATRIC TRANSPLANTS Pediatric allo-SCT for malignant and non-malignant diseases: impact on health-related quality of life outcomes J A Oberg, J G Bender, E Morris, L Harrison, C E Basch, J H Garvin, S A Sands and M S Cairo Bone Marrow Transplant 2013 48: 787-793; advance online publication, November 19, 2012; 10.1038/bmt.2012.217 Abstract | Full Text ALLOGRAFTING Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT L Castagna, R Boubdallah, S Furst, D Coso, J El Cheikh, C Faucher, R Crocchiolo, A Granata, C Chabannon, C Lemarié, B Calmels, J M Boher, M Mothy and D Blaise Bone Marrow Transplant 2013 48: 794-798; advance online publication, December 10, 2012; 10.1038/bmt.2012.225 Abstract | Full Text Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm M Unteregger, A Valentin, W Zinke-Cerwenka, K Troppan, A Deutsch, L Cerroni, W Linkesch and P Neumeister Bone Marrow Transplant 2013 48: 799-802; advance online publication, December 3, 2012; 10.1038/bmt.2012.242 Abstract | Full Text MICROBIAL ISSUES Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients P Hiwarkar, H B Gaspar, K Gilmour, M Jagani, R Chiesa, N Bennett-Rees, J Breuer, K Rao, C Cale, N Goulden, G Davies, P Amrolia, P Veys and W Qasim Bone Marrow Transplant 2013 48: 803-808; advance online publication, November 26, 2012; 10.1038/bmt.2012.221 Abstract | Full Text Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation S Cesaro, M Pillon, G Tridello, M Aljurf, R Martino, W Schroyens, C Nozzoli, P Barba, M Faraci, F Fagioli, B Cappelli, C Cordonnier, F Al-Mohareb, Y Floisand, J Greil, I S Panizzolo and S Santarone Bone Marrow Transplant 2013 48: 809-813; advance online publication, December 10, 2012; 10.1038/bmt.2012.247 Abstract | Full Text POST-TRANSPLANT EVENTS Chest health surveillance utility in the early detection of bronchiolitis obliterans syndrome in children after allo-SCT A Gassas, H Craig-Barnes, S Dell, J Doyle, T Schechter, L Sung, M Egeler and N Palaniyar Bone Marrow Transplant 2013 48: 814-818; advance online publication, November 19, 2012; 10.1038/bmt.2012.228 Abstract | Full Text Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis A Bergeron, C Godet, S Chevret, G Lorillon, R Peffault de Latour, T de Revel, M Robin, P Ribaud, G Socié and A Tazi Bone Marrow Transplant 2013 48: 819-824; advance online publication, December 3, 2012; 10.1038/bmt.2012.241 Abstract | Full Text Effects of spleen status on early outcomes after hematopoietic cell transplantation G Akpek, M C Pasquini, B Logan, M-A Agovi, H M Lazarus, D I Marks, M Bornhaeüser, O Ringdén, R T Maziarz, V Gupta, U Popat, D Maharaj, B J Bolwell, J D Rizzo, K K Ballen, K R Cooke, P L McCarthy and V T Ho On Behalf of the Regimen Related Toxicity and Supportive Care Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR) Bone Marrow Transplant 2013 48: 825-831; advance online publication, December 10, 2012; 10.1038/bmt.2012.249 Abstract | Full Text The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial Z Jahangard-Rafsanjani, K Gholami, M Hadjibabaie, A R Shamshiri, K Alimoghadam, A Sarayani, M Mojtahedzadeh, M Ostadali-Dehaghi and A Ghavamzadeh Bone Marrow Transplant 2013 48: 832-836; advance online publication, January 7, 2013; 10.1038/bmt.2012.250 Abstract | Full Text GRAFT-VERSUS-TUMOR EFFECTS Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation G W Basak, L C de Wreede, A van Biezen, W Wiktor-Jedrzejczak, K Halaburda, C Schmid, N Schaap, F Dazzi, P A von dem Borne, E Petersen, D Beelen, A Abayomi, L Volin, A Buzyn, G Gurman, D Bunjes, C Guglielmi, E Olavarria and T de Witte Chronic Malignancies Working Party EBMT. Bone Marrow Transplant 2013 48: 837-842; advance online publication, November 26, 2012; 10.1038/bmt.2012.234 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion S Al Hashmi, B Sadeghi, Z Hassan, M Abedi-Valugerdi, M Lindskog and M Hassan Bone Marrow Transplant 2013 48: 843-848; advance online publication, November 26, 2012; 10.1038/bmt.2012.227 Abstract | Full Text Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia L Wang, M Romero, P Ratajczak, C Lebœuf, S Belhadj, R Peffault de Latour, W-L Zhao, G Socié and A Janin Bone Marrow Transplant 2013 48: 849-853; advance online publication, December 10, 2012; 10.1038/bmt.2012.237 Abstract | Full Text TLI in refractory chronic GVHD R Devillier, L Castagna, L Gonzague, J El-Cheikh, S Fürst, C Faucher, R Michel and D Blaise Bone Marrow Transplant 2013 48: 854-858; advance online publication, December 10, 2012; 10.1038/bmt.2012.240 Abstract | Full Text Frequency of CD4+FOXP3+ regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD T Fujioka, H Tamaki, K Ikegame, S Yoshihara, K Taniguchi, K Kaida, R Kato, T Inoue, J Nakata, S Ishii, T Soma, M Okada and H Ogawa Bone Marrow Transplant 2013 48: 859-864; advance online publication, November 19, 2012; 10.1038/bmt.2012.232 Abstract | Full Text QUALITY OF LIFE Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation N S Majhail, J D Rizzo, T Hahn, S J Lee, P L McCarthy, M Ammi, E Denzen, R Drexler, S Flesch, H James, N Omondi, T L Pedersen, E Murphy and K Pederson Bone Marrow Transplant 2013 48: 865-871; advance online publication, December 10, 2012; 10.1038/bmt.2012.248 Abstract | Full Text Letters to the Editor Top Second cancers early post allogeneic transplant: the case of ‘unrestrained’ malignancy? J K Davidson-Moncada, S Pittaluga, M Roth, K Dunleavy, A Duffy and S Pavletic Bone Marrow Transplant 2013 48: 872-874; advance online publication, December 10, 2012; 10.1038/bmt.2012.238 Full Text Dasatinib medication causing profound immunosuppression in a patient after haploidentical SCT: functional assays from whole blood as diagnostic clues M Wölfl, F Langhammer, V Wiegering, M Eyrich and P G Schlegel Bone Marrow Transplant 2013 48: 875-877; advance online publication, December 10, 2012; 10.1038/bmt.2012.246 Full Text Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT A Rovó, M Aljurf, S Chiodi, S Spinelli, N Salooja, G Sucak, A Hunter, T S Kim, G Socié, M T van Lint, J R Passweg, M Arat, M Badoglio and A Tichelli on behalf of the Late Effects Working Party of the EBMT Bone Marrow Transplant 2013 48: 878-879; advance online publication, January 7, 2013; 10.1038/bmt.2012.255 Full Text Call for case histories of BMT in patients with coincident schizophrenia Open I E Sommer and D W van Bekkum Bone Marrow Transplant 2013 48: 880; advance online publication, March 18, 2013; 10.1038/bmt.2013.30 Full Text Advertisement Choose Scientific Reports for fast, efficient, open access publishing  93% of authors said they are likely or very likely to recommend Scientific Reports to their colleagues* 92% of authors would publish in Scientific Reports again*    SUBMIT your paper today! *Nature Publishing Group author survey, data correct as of April 2013   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.